NATALIE BASART: Open Payments
NPI 1588370761 · PLANTATION, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,489 in 167 payments from 18 companies in 2025. Trend: 2023 $876 · 2024 $3,101 · 2025 $4,489
Food & beverage: $4,489
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 30 | $795 |
| Neurocrine BioSciences, Inc. | 16 | $628 |
| Janssen Pharmaceuticals, Inc | 23 | $623 |
| Teva Pharmaceuticals USA, Inc. | 18 | $442 |
| ABBVIE INC. | 21 | $366 |
| Otsuka America Pharmaceutical, Inc. | 9 | $234 |
| Vanda Pharmaceuticals Inc. | 8 | $232 |
| E.R. Squibb & Sons, L.L.C. | 5 | $206 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $179 |
| Lundbeck LLC | 7 | $135 |
Products named: Auvelity, INGREZZA, INVEGA SUSTENNA, VRAYLAR, AUSTEDO XR, REXULTI, COBENFY, HETLIOZ.
Industry payments across FL — which companies pay providers there.
